【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 10
1.1 List of Tables 16
1.2 List of Figures 21
2 Introduction 23
2.1 Catalyst 23
2.2 Related Reports 24
2.3 Upcoming Related Reports 24
3 Disease Overview 25
3.1 Etiology and Pathophysiology 25
3.1.1 Etiology 25
3.1.2 Pathophysiology 27
3.2 Clinical Staging 28
3.3 Symptoms 29
4 Epidemiology 31
4.1 Disease Background 31
4.2 Risk Factors and Comorbidities 31
4.3 Global Trends 34
4.3.1 8MM, Incidence Trends 34
4.3.2 8MM, Five-Year Relative Survival 36
4.3.3 8MM, Screening Programs for CRC 37
4.4 Forecast Methodology 39
4.4.1 Sources Used 40
4.4.2 Sources Not Used 47
4.4.3 Forecast Assumptions and Methods 48
4.5 Epidemiological Forecast of CRC (2013-2023) 52
4.5.1 Diagnosed Incident Cases of CRC 52
4.5.2 Age-Specific Diagnosed Incident Cases of CRC 54
4.5.3 Sex-Specific Diagnosed Incident Cases of CRC 55
4.5.4 Age-Standardized Incidence 57
4.5.5 Cancer Stage at Diagnosis 58
4.5.6 Diagnosed Five-Year Prevalent Cases of CRC 59
4.5.7 KRAS Status among Diagnosed Five-Year Prevalent Cases of CRC 61
4.6 Discussion 61
4.6.1 Epidemiological Forecast Insight 61
4.6.2 Limitations of the Analysis 63
4.6.3 Strengths of the Analysis 64
5 Disease Management 65
5.1 Diagnosis and Treatment Overview 65
5.1.1 Screening and Diagnosis 65
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 68
5.1.3 Clinical Practice 72
5.2 US 78
5.2.1 Screening and Diagnosis 80
5.2.2 Clinical Practice 81
5.3 France 83
5.3.1 Screening and Diagnosis 85
5.3.2 Clinical Practice 85
5.4 Germany 87
5.4.1 Screening and Diagnosis 89
5.4.2 Clinical Practice 89
5.5 Italy 91
5.5.1 Screening and Diagnosis 93
5.5.2 Clinical Practice 93
5.6 Spain 95
5.6.1 Screening and Diagnosis 97
5.6.2 Clinical Practice 97
5.7 UK 99
5.7.1 Screening and Diagnosis 101
5.7.2 Clinical Practice 101
5.8 Japan 103
5.8.1 Screening and Diagnosis 105
5.8.2 Clinical Practice 105
5.9 China 107
5.9.1 Screening and Diagnosis 108
5.9.2 Clinical Practice 108
6 Competitive Assessment 110
6.1 Overview 110
6.2 Product Profiles — Major Brands 111
6.2.1 Avastin (Bevacizumab) 111
6.2.2 Erbitux (Cetuximab) 117
6.2.3 Vectibix (Panitumumab) 122
6.2.4 Stivarga (Regorafenib) 126
6.2.5 Zaltrap (Ziv-Aflibrcept) 131
6.2.6 Lonsurf (TAS-102) 135
6.2.7 TS-1 (Tegafur, Gimeracil, Oteracil) 140
6.2.8 Xeloda (Capecitabine) 144
7 Unmet Need and Opportunity 148
7.1 Overview 148
7.2 Therapies That Provide Substantial Overall Survival Benefit for Metastatic Patients 149
7.2.1 Unmet Need 149
7.2.2 Gap Analysis 151
7.2.3 Opportunity 151
7.3 Targeted Treatments for KRAS and BRAF Mutaton-Positive Patients 153
7.3.1 Unmet Need 153
7.3.2 Gap Analysis 154
7.3.3 Opportunity 154
7.4 Effective Neoadjuvant/Adjuvant Therapies for High Risk Resectable Disease 155
7.4.1 Unmet Need 155
7.4.2 Gap Analysis 156
7.4.3 Opportunity 156
7.5 Tolerable Later-Line Therapies For Chemotherapy-Resistant Patients 157
7.5.1 Unmet Need 157
7.5.2 Gap Analysis 157
7.5.3 Opportunity 158
8 Pipeline Assessment 159
8.1 Overview 159
8.2 Promising Drugs in Clinical Development 160
8.2.1 Cyramza (Ramucirumab) 161
8.2.2 Imprime PGG 167
8.2.3 MGN1703 173
8.2.4 Nintedanib (BIBF-1120) 179
8.3 Promising Approaches in Early-Stage Development 184
8.3.1 Anti-Angiopoietin-2 Inhibitors 184
8.3.2 Strategies for BRAF Mutation-Positive Disease 186
8.3.3 Strategies for KRAS-Mutation Positive Disease 192
8.3.4 Immune Checkpoint Inhibitors 196
9 Current and Future Players 201
9.1 Overview 201
9.2 Trends in Corporate Strategy 205
9.3 Company Profiles 207
9.3.1 Roche/Genentech 207
9.3.2 Sanofi 211
9.3.3 Eli Lilly and Company 214
9.3.4 Merck KGaA 217
9.3.5 Bayer 220
9.3.6 Taiho Pharmaceutical 223
10 Market Outlook 226
10.1 Global Markets 226
10.1.1 Forecast 226
10.1.2 Drivers and Barriers – Global Issues 230
10.2 United States 233
10.2.1 Forecast 233
10.2.2 Key Events 237
10.2.3 Drivers and Barriers 237
10.3 France 240
10.3.1 Forecast 240
10.3.2 Key Events 244
10.3.3 Drivers and Barriers 244
10.4 Germany 247
10.4.1 Forecast 247
10.4.2 Key Events 251
10.4.3 Drivers and Barriers 251
10.5 Italy 253
10.5.1 Forecast 253
10.5.2 Key Events 257
10.5.3 Drivers and Barriers 257
10.6 Spain 259
10.6.1 Forecast 259
10.6.2 Key Events 263
10.6.3 Drivers and Barriers 263
10.7 United Kingdom 265
10.7.1 Forecast 265
10.7.2 Key Events 269
10.7.3 Drivers and Barriers 269
10.8 Japan 272
10.8.1 Forecast 272
10.8.2 Key Events 276
10.8.3 Drivers and Barriers 276
10.9 China 278
10.9.1 Forecast 278
10.9.2 Key Events 282
10.9.3 Drivers and Barriers 282
11 Appendix 286
11.1 Bibliography 286
11.2 Abbreviations 322
11.3 Methodology 329
11.4 Forecasting Methodology 329
11.4.1 Diagnosed Colorectal Cancer Patients 329
11.4.2 Percent Drug-Treated Patients 330
11.4.3 Drugs Included in Each Therapeutic Class 330
11.4.4 Launch and Patent Expiration Dates 331
11.4.5 General Pricing Assumptions 332
11.4.6 Average Body Weight and Surface Area Across the 8MM 333
11.4.7 Individual Drug Assumptions 333
11.4.8 Generic Erosion 339
11.4.9 Pricing of Pipeline Agents 339
11.5 Primary Research – KOLs Interviewed for this Report 340
11.6 Primary Research – Prescriber Survey 342
11.7 About the Authors 343
11.7.1 Analyst 343
11.7.2 Epidemiologist 343
11.7.3 Global Head of Healthcare 344
11.8 About GlobalData 345
11.9 Disclaimer 345
【レポート販売概要】
■ タイトル：大腸がん（Colorectal Cancer）治療薬の世界市場予測および分析■ 英文：PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023
■ 発行日：2014年11月30日
■ 調査会社：GlobalData
■ 商品コード：GDHC95PIDR
■ 調査対象地域：グローバル
- ベンディングビーム型ロードセルの世界市場展望2017-20276According to Stratistics MRC, the Global Bending Beam Load Cells market is expected to grow at a CAGR of 4.8% during the forecast period. Some of the key factors such as increasing usage of these cells in aerospace for the in-flight test, ground test, or even onboard aircraft measurements and automotive industries for the development and to monitor the performance of equipment installed in vehicle …
- South AfricaのHydrogen Fluoride (Hydrofluoric Acid)市場：貿易（輸入、輸出）動向This market research report examines the foreign trade of South Africa and its perspectives on the global market for hydrogen fluoride (hydrofluoric acid). The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on hydrogen fluoride (hydrofluoric acid) export/import operations i …
- ウェアラブル電子機器の世界市場：スマートグラス、スマートウォッチ、HMD、スマートバンド、スマート衣服About wearable electronics Wearable electronics refers to electronics embedded in wearables, such as accessories and clothing. Wearable electronics are equipped with miniaturized devices such as microchips and sensors, which provide them the capability to compute like cell phones and laptops. The electronic devices embedded in wearables collet data and track activities, allowing wearers access to …
- 垂直離着陸無人機（VTOL UAV）の世界市場：マルチコプターUAV、ヘリコプターUAV、ハイブリッドUAVThe global VTOL UAV market is estimated to be valued at USD 2,235.40 million in 2015 and is projected to reach USD 5,500 million by 2020, at a CAGR of 19.73% from 2015 to 2020. The growth in the market is attributed to factors such as increasing demand in commercial and law enforcement applications, better technological advancements, amended safety norms to perform complex operations with least hu …
- 塩化カルシウム(CaCl2)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world calcium chloride market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true …
- Abu Dhabi National Energy Company PJSC：発電所及びSWOT分析2013Abu Dhabi National Energy Company PJSC - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (asset …
- フェイスメイクアップの世界市場：ファンデーション、フェイスパウダー、ブラシ、コンシーラー、ブロンザーAbout the Face Make-Up Market In 2015, the face make-up segment was the highest revenue generator in the global color cosmetics market, accounting for 37.46% of its revenue. In the US, bronzers and blushers were the top-selling beauty products in 2015, with sales increasing due to the rise of the contouring and face mapping trends. Smashbox’s Step-By-Step Contour Kit is one of Sephora's top three …
- ディープラーニング（深層学習）の世界市場予測（～2022）： 画像認識、信号認識、データマイニングAccording to the new market research report on deep learning, this market is expected to be worth USD 1,772.9 Million by 2022, growing at a CAGR of 65.3% between 2016 and 2022. The major driver for the growth is the growing usage of deep learning technology across various industrial vertical such as advertisement, finance, automotive, medical and among other. Other important drivers for this marke …
- 世界の航空宇宙用複合材料市場動向（2014-2018）TechNavio’s analysts forecast the Global Aerospace Composites market will grow at a CAGR of 11.85 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased adoption of composites in aircraft design. The Global Aerospace Composites market has also been witnessing the growth of the Aerospace industry in the APAC region. However, the lack of product …
- 世界の糖尿病網膜症市場動向（2012-2016）TechNavio's analysts forecast the Global Diabetic Retinopathy Market to grow at a CAGR of 35.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the Increase in Diabetic Population Worldwide. The Global Diabetic Retinopathy Market has also been witnessing the Increased Focus on Combination Therapies. However, the Availability of Effective Surgical Tre …
- グローバル・瘢痕治療（Scar Treatment）市場動向（2014-2018）About Scar Treatment Scar treatment products are applied on a scar to treat, heal, and conceal the scar. Products such as gels, creams, oils, and sprays are available as OTC products or are prescribed to treat scars. They are an alternative to invasive surgical treatment, laser treatment, elastic wraps, and gel sheets. Scar treatment application products are easy to use and cost-effective in compa …
- 組織診断の世界市場予測（～2022年）：消耗品、装置、技術、疾患、エンドユーザー“Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period”The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technologica …
- DRaaS(Disaster Recovery as a Service)の世界市場2015-2019About Disaster Recovery as a Service Disaster recovery as a service refers to services that offer business continuity by enabling data backup, recovery, and retrieval. It is one of the fastest growing segment in the cloud-based recovery model under infrastructure as a service market. It can help enterprises to record business critical data files during the occurrence of natural calamities such as …
- ウェアラブル医療機器の世界市場分析：製品別（診断用、治療用デバイス）、用途別（ハンドヘルド、ヘッドバンド、ストラップ/クリップ/ブレスレット、靴センサー）、セグメント予測Global Wearable Medical Device Market is expected to reach USD 27.8 billion by 2022, according to a new report by Grand View Research, Inc. Rising prevalence of conditions such as obesity and hypertension, as a result of sedentary lifestyle is anticipated to boost the demand for wearable medical devices. Moreover, increasing health awareness is further expected to augment the demand for these devi …
- 線量測定器の世界市場ABSTRACTAbout Dosimetry Equipment Dosimetry equipment is used to measure the amount of energy deposited by ionizing radiation. The devices are used to measure and estimate the effective dose received by the human body through exposure to external ionizing radiation. Dosimetry equipment devices are used in places where people deal with hazardous waste or radioactive substances such as hospitals and …
